Citichem India Ltd
Incorporated in 1992, Citichem India Limited is engaged in buying and supplying organic and inorganic chemicals, bulk drugs, and food chemicals to the pharmaceutical industry.[1]
- Market Cap ₹ 17.0 Cr.
- Current Price ₹ 25.0
- High / Low ₹ 70.0 / 25.0
- Stock P/E 9.51
- Book Value ₹ 30.6
- Dividend Yield 0.00 %
- ROCE 11.6 %
- ROE 8.91 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.82 times its book value
- Company's working capital requirements have reduced from 107 days to 58.2 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -15.6% over past five years.
- Company has a low return on equity of 11.2% over last 3 years.
- Contingent liabilities of Rs.21.4 Cr.
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.1.03 Cr.
- Company has high debtors of 343 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Trading - Chemicals
Part of BSE SME IPO
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 127.35 | 180.17 | 85.22 | 20.94 | 19.61 | 54.37 | 62.80 | |
| 0.02 | 127.07 | 179.96 | 84.84 | 20.36 | 17.81 | 52.75 | 60.82 | |
| Operating Profit | -0.02 | 0.28 | 0.21 | 0.38 | 0.58 | 1.80 | 1.62 | 1.98 |
| OPM % | 0.22% | 0.12% | 0.45% | 2.77% | 9.18% | 2.98% | 3.15% | |
| 0.00 | 0.01 | 0.11 | 0.06 | 0.00 | 0.00 | 0.36 | 1.03 | |
| Interest | 0.00 | 0.01 | 0.00 | 0.10 | 0.06 | 0.07 | 0.31 | 0.57 |
| Depreciation | 0.00 | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 | 0.03 |
| Profit before tax | -0.02 | 0.27 | 0.30 | 0.32 | 0.51 | 1.71 | 1.66 | 2.41 |
| Tax % | 0.00% | 25.93% | 26.67% | 28.12% | 29.41% | 18.71% | 25.90% | |
| -0.02 | 0.20 | 0.22 | 0.24 | 0.36 | 1.39 | 1.23 | 1.79 | |
| EPS in Rs | 0.48 | 0.72 | 2.78 | 1.81 | 2.63 | |||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -16% |
| 3 Years: | -14% |
| TTM: | 177% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 44% |
| 3 Years: | 72% |
| TTM: | -12% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 11% |
| 3 Years: | 11% |
| Last Year: | 9% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.07 | 0.07 | 0.07 | 5.00 | 5.00 | 5.00 | 6.80 | 6.80 |
| Reserves | 0.15 | 0.31 | 0.53 | 0.77 | 1.13 | 2.52 | 13.30 | 13.98 |
| 0.11 | 0.37 | 0.00 | 1.11 | 1.10 | 1.08 | 5.39 | 7.05 | |
| 0.01 | 31.98 | 72.62 | 84.55 | 72.50 | 60.73 | 44.43 | 29.94 | |
| Total Liabilities | 0.34 | 32.73 | 73.22 | 91.43 | 79.73 | 69.33 | 69.92 | 57.77 |
| 0.01 | 0.08 | 0.09 | 0.08 | 0.10 | 0.10 | 0.06 | 0.96 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 0.32 | 32.64 | 73.13 | 91.35 | 79.63 | 69.23 | 69.86 | 56.81 | |
| Total Assets | 0.34 | 32.73 | 73.22 | 91.43 | 79.73 | 69.33 | 69.92 | 57.77 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 0.37 | 0.38 | -5.95 | 0.28 | 0.49 | -11.51 | ||
| -0.01 | -0.02 | -0.01 | -0.04 | 0.00 | 0.03 | ||
| -0.42 | -0.37 | 5.94 | -0.07 | -0.08 | 15.35 | ||
| Net Cash Flow | -0.07 | -0.02 | -0.03 | 0.17 | 0.41 | 3.86 |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 5.53 | 68.05 | 198.73 | 595.78 | 569.18 | 342.91 | |
| Inventory Days | 76.06 | 70.95 | 180.36 | 857.35 | 849.40 | 45.66 | |
| Days Payable | 92.27 | 148.47 | 367.79 | 1,378.23 | 1,348.08 | 315.43 | |
| Cash Conversion Cycle | -10.68 | -9.47 | 11.30 | 74.90 | 70.51 | 73.15 | |
| Working Capital Days | 1.63 | 0.85 | 28.70 | 118.01 | 144.99 | 58.20 | |
| ROCE % | 44.44% | 11.23% | 8.08% | 22.49% | 11.56% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Issue of Securities
14 Nov - Board approved H1 results and proposed 4.7m warrants at Rs29 each (INR13.63 Cr) via preferential allotment.
-
Announcement under Regulation 30 (LODR)-Preferential Issue
14 Nov - Board approved H1 results; proposed 4,700,000 warrants at Rs29 raising INR136.3mn; EGM and approvals required.
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th November, 2025
14 Nov - Board approved H1 results and proposed 4.7M warrants at Rs29 (INR136.3M); EGM and approvals required.
-
Unaudited Financial Results Of The Company For The Half Year Ended 30Th September, 2025
14 Nov - Board approved 4,700,000 warrants at Rs29 each (INR136.3mn), convertible within 18 months; EGM approval required.
-
Board Meeting Intimation for Unaudited Financial Results And Issuance Of Warrants
10 Nov - Board meeting 14 Nov 2025 to approve H1 (30 Sep 2025) results and proposed equity/warrants fundraise (preferential/private placement).
Business Overview[1]
Citichem India Limited is engaged in trading and supplying organic and inorganic chemicals, bulk drugs, and food chemicals to various industries, including pharmaceuticals, aluminum, steel, textiles, paper, dairy, paints, dyes, soaps, and adhesives.